NANOPORTAL Trademark of Second Sight Medical Products, Inc. - Serial Number 97382032

NANOPORTAL Trademark

Trademark Overview

On Tuesday, April 26, 2022, a trademark application was filed for NANOPORTAL with the United States Patent and Trademark Office. The USPTO has given the NANOPORTAL trademark a serial number of 97382032. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Thursday, December 14, 2023. This trademark is owned by Second Sight Medical Products, Inc.. The NANOPORTAL trademark is filed in the Chemical Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:

Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy

Nanoporous membranes used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant

Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; Nanoporous membranes used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy del...

General Information

Serial Number	97382032
Word Mark	NANOPORTAL
Filing Date	Tuesday, April 26, 2022
Status	654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status Date	Thursday, December 14, 2023
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

Goods and Services	Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy
Goods and Services	Nanoporous membranes used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant
Goods and Services	Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; Nanoporous membranes used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules

Classification Information

International Class	001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes	001, 005, 006, 010, 026, 046
Class Status Code	6 - Active
Class Status Date	Saturday, May 13, 2023
Primary Code	001
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	005, 006, 018, 044, 046, 051, 052
Class Status Code	6 - Active
Class Status Date	Saturday, May 13, 2023
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

International Class	010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes	026, 039, 044
Class Status Code	6 - Active
Class Status Date	Monday, May 2, 2022
Primary Code	010
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	Second Sight Medical Products, Inc.
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Sylmar, CA 91342

Trademark Events

Event Date	Event Description
Thursday, December 14, 2023	REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, May 30, 2023	NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 30, 2023	LETTER OF SUSPENSION E-MAILED
Tuesday, May 30, 2023	SUSPENSION LETTER WRITTEN
Saturday, May 13, 2023	TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 12, 2023	CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 12, 2023	TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 15, 2023	NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 15, 2023	NON-FINAL ACTION E-MAILED
Wednesday, February 15, 2023	NON-FINAL ACTION WRITTEN
Monday, February 13, 2023	ASSIGNED TO EXAMINER
Monday, May 2, 2022	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 29, 2022	NEW APPLICATION ENTERED

Related Keywords

nanoportal drug diseases small needle nanoporous through such injected delivery rate